Epistem (AIM: EHP), the rapidly growing biotechnology company, announces a pre-close trading statement for the year ended 30th June 2010.
Following a very positive year during which sales in all of the Company's business divisions have made strong progress, the Company is pleased to announce that trading over the year was in line with market forecasts and the Company expects to report growth in year on year after tax profit.
The Company expects to release its final results for the year ended 30th June 2010 on Tuesday 5th October 2010 and will hold an analysts' meeting on the day.